(19)
(11) EP 0 619 836 A1

(12)

(43) Date of publication:
19.10.1994 Bulletin 1994/42

(21) Application number: 93900825.0

(22) Date of filing: 01.12.1992
(51) International Patent Classification (IPC): 
C12N 5/ 00( . )
C12N 1/ 21( . )
C12N 15/ 09( . )
A61K 38/ 00( . )
C07K 14/ 71( . )
C12N 5/ 10( . )
C12P 21/ 02( . )
C12R 1/ 91( . )
(86) International application number:
PCT/US1992/010430
(87) International publication number:
WO 1993/011223 (10.06.1993 Gazette 1993/14)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 02.12.1991 US 19910801794

(71) Applicant: COR THERAPEUTICS, INC.
South San Francisco, CA 94080 (US)

(72) Inventors:
  • WOLF, David
    Palo Alto, CA 94303 (US)
  • TOMLINSON, James, E.
    Burlingame, CA 94010 (US)

(74) Representative: Thomson, Paul Anthony 
Potts, Kerr & Co. 15, Hamilton Square
Birkenhead Merseyside L41 6BR
Birkenhead Merseyside L41 6BR (GB)

   


(54) METHODS FOR PRODUCTION OF PURIFIED SOLUBLE TYPE B AND TYPE A HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR FRAGMENTS